Target Gene Therapy for α-Fetoprotein-Producing Hepatocellular Carcinoma by E1B55k-Attenuated Adenovirus
- 30 March 2001
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 282 (2) , 529-535
- https://doi.org/10.1006/bbrc.2001.4573
Abstract
No abstract availableKeywords
Funding Information
- Ministerie van Onderwijs, Cultuur en Wetenschap
- Ministry of Health, Labour and Welfare
This publication has 17 references indexed in Scilit:
- A controlled trial of intratumoral ONYX-015, a selectively-replicating adenovirus, in combination with cisplatin and 5-fluorouracil in patients with recurrent head and neck cancerNature Medicine, 2000
- The Prevalence of Hepatitis C Virus Infection in the United States, 1988 through 1994New England Journal of Medicine, 1999
- Hepatocellular carcinomaThe Lancet, 1999
- Rising Incidence of Hepatocellular Carcinoma in the United StatesNew England Journal of Medicine, 1999
- ONYX-015: Clinical data are encouragingNature Medicine, 1998
- p53-dependent cell death/apoptosis is required for a productive adenovirus infectionNature Medicine, 1998
- An Adenovirus Mutant That Replicates Selectively in p53- Deficient Human Tumor CellsScience, 1996
- Efficient generation of recombinant adenoviruses using adenovirus DNA-terminal protein complex and a cosmid bearing the full-length virus genome.Proceedings of the National Academy of Sciences, 1996
- Efficient selection for high-expression transfectants with a novel eukaryotic vectorGene, 1991
- Alpha-Fetoprotein in Ontogenesis and its Association with Malignant TumorsAdvances in Cancer Research, 1971